Results 21 to 30 of about 1,912,136 (307)
Background: to explore the diagnostic accuracy of 18F-Fluciclovine positron-emission tomography (PET) in prostate cancer (PCa), considering both primary staging prior to radical therapy, biochemical recurrence, and advanced setting. Methods: A systematic
Giuseppina Biscontini +7 more
doaj +1 more source
Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent condition with the possible risk of progression to multiple myeloma (MM) or a lymphoproliferative neoplasm in a small percentage of patients.
Giorgio Treglia +2 more
doaj +1 more source
Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) [PDF]
The purpose of this study was to analyze the detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (FDG-PET/CT). Data for a total of 492 patients who had undergone both PET/CT
Saito, Shunsuke +25 more
core +1 more source
PET-CT in brain disorders: The South African context
Positron emission tomography combined with X-ray computed tomography (PET-CT) has an established role in the management of brain disorders, but may be underutilised in South Africa.
Alexander G.G. Doruyter +3 more
doaj +1 more source
Bayesian model comparison for compartmental models with applications in positron emission tomography [PDF]
We develop strategies for Bayesian modelling as well as model comparison, averaging and selection for compartmental models with particular emphasis on those that occur in the analysis of positron emission tomography (PET) data.
Aston, John A. D. +2 more
core +1 more source
Cerebral Metabolism Related to Cognitive Impairments in Multiple System Atrophy
Objective: We aimed to characterize the cognitive profiles in multiple system atrophy (MSA) and explore the cerebral metabolism related to the cognitive decline in MSA using 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET).Methods: In ...
Cong Shen +12 more
doaj +1 more source
Opportunities for PET to deliver clinical benefit in cancer:breast cancer as a paradigm [PDF]
The glucose analogue fluorodeoxyglucose (FDG) has demonstrated enhanced uptake in the majority of tumours as a result of increased uptake and fixation by phosphorylation. It is the most widely used radiotracer in positron emission tomography (PET), being
Ken A. Miles +11 more
core +1 more source
[11C]-L-Methionine positron emission tomography in the management of children and young adults with brain tumors [PDF]
Only a few Methyl-[11C]-l-methionine (MET) positron emission tomography (PET) studies have focused on children and young adults with brain neoplasm. Due to radiation exposure, long scan acquisition time, and the need for sedation in young children MET ...
Johannes C. Klein +27 more
core +1 more source
Positron emission tomography compartmental models: A basis pursuit strategy for kinetic modelling
A kinetic modelling approach for the quantification of in vivo tracer studies with dynamic positron emission tomography (PET) is presented. The approach is based on a general compartmental description of the tracer’s fate in vivo and determines a ...
Roger N. Gunn +14 more
core +2 more sources
ObjectivesTo explore the feasibility of predicting the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade and progression-free survival (PFS) of clear cell renal cell cancer (ccRCC) using the radiomics features (RFs)
Fu Yin +7 more
doaj +1 more source

